Subject: Considerations for PCI in Cancer Patients and Survivors
Recent studies have shed light on the complex comorbidities of percutaneous coronary intervention in patients with cancer diagnoses. Bleeding “remains a concern” for PCI in cancer patients, but results are encouraging for newer generation drug-eluting stents.
Accreditation for Cardiovascular Excellence's latest Quality Matters news brief takes a look at the latest developments and some of the available resources and overviews of considerations for clinicians when navigating PCI with patients with cancer or who are cancer survivors.
Discussion of navigating PCI in this particularly high-risk population calls to attention the crucial importance of establishing sophisticated continuous quality improvement and creating a quality culture for your organization’s cardiology team. Quality accreditation can help.
- Kurt Jensen
Communications Director
Accreditation for Cardiovascular Excellence
Association/Foundation Headquarters, PO Box 2007, 23113, Midlothian, United States
